We conducted a trial to clarify the therapeutic role of intrapleural streptokinase.
我们进行了一项试验,以阐明胸膜腔内应用链激酶的治疗作用.
Intrapleural streptokinase for pleural infection A step forward in managing pleural effusions?
胸膜腔内滴注链激酶治疗胸膜腔感染这是胸膜腔积液治疗的进步 吗 ?
To test this hypothesis, we evaluated the effect of low - dose intracoronary streptokinase administered immediately after PCI.
为了检验该假说, 我们评估在首次经皮冠脉介入后立即冠状动脉内注射低剂量的链激酶的效果.